Other Trials Clinical Trials

Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash

This is a clinical research study of an experimental new medication, Menadione Topical Lotion (MTL). The study lotion is experimental and has not been approved for public use. Hana Biosciences, Inc...

Diagnosis: Other Trials

Phase: 1

Protocol Number:

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease

The objectives of this study are to evaluate the immediate tolerability and safety of rVWF:rFVIII in subjects with Type 3 Von Willebrand Disease after administration of various dosages of VWF:RCo.

Diagnosis: Other Trials

Phase:

Protocol Number: 09-239

Randomized Study of a Hospice Video Educational Tool for Patients With Advanced Cancer and Their Caregivers

The purpose of this research study is to compare two ways to educate patients with cancer and their caregivers about hospice care services

Diagnosis: Other Trials

Phase:

Protocol Number: 17-026

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

Psychological interventions for cancer patients have been tested and found to reduce stress and improve quality of life. These interventions have been tested at academic medical centers but have no...

Diagnosis: Other Trials

Phase:

Protocol Number: 16-033

Efficacy and Safety of Maribavir in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment

The purpose of this study is to determine if an investigational treatment (Maribavir) is safe and effective in treating transplant recipient patients with cytomegalovirus (CMV) infections that are ...

Diagnosis: Other Trials

Phase:

Protocol Number: 17-705

Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma

This pilot phase II trial studies how well nelfinavir mesylate works in treating patients with kaposi sarcoma. Nelfinavir mesylate may stop the growth of tumor cells by blocking some of the enzymes...

Diagnosis: Cutaneous Skin Cancer, Other Trials

Phase:

Protocol Number: 16-388

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

The purpose of this study is to demonstrate that rivaroxaban is superior to placebo for reducing the risk of the primary composite outcome as defined by objectively confirmed symptomatic lower extr...

Diagnosis: Solid Tumor/Phase I, Other Trials

Phase:

Protocol Number: 16-547

ALXN1210 Versus Eculizumab in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

The purpose of this study is to assess ALXN1210 compared to eculizumab in adult patients with PNH who are clinically stable on eculizumab for at least 6 months

Diagnosis: Other Trials

Phase:

Protocol Number: 17-178